jens juul holst glp-1 New book by Professor about the history of 🎉 Find out more info about the book – and book reception – below 💡 The Story of GLP-1: A

A new GLP-1 medication demonstrated efficacy in reducing blood sugar in people with type 2 diabetes in a phase 2b clinical trial

In clinical trials, participants who took the highest dose of the pill lost an average of 16.6 percent of their body weight (approximately 32 pounds for a 200-pound person) after 64 weeks, the drugs manufacturer, Novo Nordisk, said in a Dec

Or are we looking at next-generation drugs that preserve muscle, or avoid more of the side effects a more standard development pathway

Patients with specific GLP1R variants may experience stronger nausea responses to caffeine stimulation, while those with favorable MC4R alleles often tolerate caffeine more effectively during semaglutide therapy